| |
| | UpToDate Aldose reductase inhibitors in the prevention of diabetic complications |
 | | Clinical trials of several antioxidants, including aldose reductase inhibitors, alpha-lipoic acid, vitamins C and E, and growth factors, in diabetic neuropathy are in progress. |
 | | To date, however, despite strong evidence that oxidative stress is associated with diabetic complications including nephropathy, retinopathy, and neuropathy, clinical trials of several antioxidants (such as aldose reductase inhibitors, alpha-lipoic acid, vitamins C and E, and growth factors) in diabetic neuropathy and retinopathy have not established therapeutic efficacy [2]. |
 | | However, erythrocyte aldose reductase activity in NIDDM is not correlated with age, duration of diabetes, fasting blood glucose, or HbA1c [7]. |
| patients.uptodate.com /topic.asp?file=glomrdis/22550 (545 words) |
|